Purpose
To improve the developability and reduce the cost of goods of monoclonal antibodies to make them more affordable and accessible and prevent infectious disease in low- and middle-income countries.
Grantee
Division
Global Health
Date
OCTOBER 2025
Region served
GLOBAL
Committed amount
$1,688,735
Grant topic
Discovery and Translational Sciences,
Malaria
Duration (months)
36
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.